Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib in Metastatic Breast Cancer
NCT00773474Phase 2Terminated
- Sponsor
- Caris Life Sciences
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lonafarnib in breast cancer, sponsored by Caris Life Sciences. Started Oct 2008; status: terminated.
02
Drugs
lonafarnib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00773474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773474.